141 related articles for article (PubMed ID: 30377340)
1. Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma.
Goeppert B; Roessler S; Renner M; Singer S; Mehrabi A; Vogel MN; Pathil A; Czink E; Köhler B; Springfeld C; Pfeiffenberger J; Rupp C; Weiss KH; Schirmacher P; von Knebel Doeberitz M; Kloor M
Br J Cancer; 2019 Jan; 120(1):109-114. PubMed ID: 30377340
[TBL] [Abstract][Full Text] [Related]
2. Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma.
Yang X; Lian B; Zhang N; Long J; Li Y; Xue J; Chen X; Wang Y; Wang Y; Xun Z; Piao M; Zhu C; Wang S; Sun H; Song Z; Lu L; Dong X; Wang A; Liu W; Pan J; Hou X; Guan M; Huo L; Shi J; Zhang H; Zhou J; Lu Z; Mao Y; Sang X; Wu L; Yang X; Wang K; Zhao H
BMC Med; 2024 Jan; 22(1):42. PubMed ID: 38281914
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of autophagy-related protein 7 enhances anti-tumor immune response and improves efficacy of immune checkpoint blockade in microsatellite instability colorectal cancer.
Zhang W; Chen L; Liu J; Chen B; Shi H; Chen H; Qi H; Wu Z; Mao X; Wang X; Huang Y; Li J; Yu Z; Zhong M; Wang T; Li Q
J Exp Clin Cancer Res; 2024 Apr; 43(1):114. PubMed ID: 38627815
[TBL] [Abstract][Full Text] [Related]
4. Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management.
Strickland MR; Lander EM; Gibson MK; Ilson DH; Ajani JA; Klempner SJ
J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38503041
[TBL] [Abstract][Full Text] [Related]
5. One-instrument, objective microsatellite instability analysis using high-resolution melt.
Bendixen KK; Forsberg-Pho S; Dazio G; Hansen EE; Eriksen SK; Epistolio S; Merlo E; Boldorini R; Venesio T; Movilia A; Caprera C; Arnspang EC; Børgesen M; Christensen UB; Frattini M; Petersen RK
PLoS One; 2024; 19(4):e0302274. PubMed ID: 38662796
[TBL] [Abstract][Full Text] [Related]
6. Stromal localization of inactive CD8
Küçükköse E; Baars MJD; Amini M; Schraa SJ; Floor E; Bol GM; Borel Rinkes IHM; Roodhart JML; Koopman M; Laoukili J; Kranenburg O; Vercoulen Y
Br J Cancer; 2024 Feb; 130(2):213-223. PubMed ID: 38042958
[TBL] [Abstract][Full Text] [Related]
7. Unexpected tumor response to palliative pelvic radiotherapy in mismatch repair-deficient advanced prostate cancer: a case report.
Aluisio G; Mazzeo E; Lohr F; Fiocchi F; Bettelli S; Baldessari C; Paterlini M; Bruni A
J Med Case Rep; 2020 Dec; 14(1):239. PubMed ID: 33287897
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy.
Cheng S; Han Z; Dai D; Li F; Zhang X; Lu M; Lu Z; Wang X; Zhou J; Li J; Guo X; Song P; Qiu C; Shen W; Zhang Q; Zhu N; Wang X; Tan Y; Kou Y; Yin X; Shen L; Peng Z
Cell Rep Med; 2024 Jan; 5(1):101355. PubMed ID: 38194971
[TBL] [Abstract][Full Text] [Related]
9. Tumor heterogeneity impairs immunogenicity in mismatch repair deficient tumors.
Reading JL; Caswell DR; Swanton C
Nat Genet; 2023 Oct; 55(10):1610-1612. PubMed ID: 37758959
[No Abstract] [Full Text] [Related]
10. Mismatch repair and microsatellite instability-Recommendation for an optimal test strategy.
Rüschoff J; Dietmaier W; Edmonston TB; Büttner R
Cancer; 2024 May; 130(9):1711-1712. PubMed ID: 38430458
[No Abstract] [Full Text] [Related]
11. Reply to "Mismatch repair and microsatellite instability-Recommendation for an optimal test strategy".
Riedinger CJ; Esnakula A; Haight PJ; Suarez AA; Chen W; Gillespie J; Villacres A; Chassen A; Cohn DE; Goodfellow PJ; Cosgrove CM
Cancer; 2024 May; 130(9):1713-1714. PubMed ID: 38430468
[No Abstract] [Full Text] [Related]
12. Successful pembrolizumab treatment of microsatellite instability-high intrahepatic cholangiocarcinoma: A case report.
Ikeda Y; Ono M; Ohmori G; Ameda S; Yamada M; Abe T; Fujii S; Fujita M; Maeda M
Clin Case Rep; 2021 Apr; 9(4):2259-2263. PubMed ID: 33936676
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor DNA and plasma microsatellite instability during PD-1 blockade.
Kasi PM
J Gastrointest Oncol; 2020 Aug; 11(4):826-828. PubMed ID: 32953165
[No Abstract] [Full Text] [Related]
14. Successful response to the combination of immunotherapy and chemotherapy in cholangiocarcinoma with high tumour mutational burden and PD-L1 expression: a case report.
Mou H; Yu L; Liao Q; Hou X; Wu Y; Cui Q; Yan N; Ma R; Wang L; Yao M; Wang K
BMC Cancer; 2018 Nov; 18(1):1105. PubMed ID: 30419854
[TBL] [Abstract][Full Text] [Related]
15. Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer.
Gao M; Lin M; Moffitt RA; Salazar MA; Park J; Vacirca J; Huang C; Shroyer KR; Choi M; Georgakis GV; Sasson AR; Talamini MA; Kim J
Br J Cancer; 2019 Jan; 120(1):88-96. PubMed ID: 30377341
[TBL] [Abstract][Full Text] [Related]
16. Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status.
Cohen R; Hain E; Buhard O; Guilloux A; Bardier A; Kaci R; Bertheau P; Renaud F; Bibeau F; Fléjou JF; André T; Svrcek M; Duval A
JAMA Oncol; 2019 Apr; 5(4):551-555. PubMed ID: 30452494
[TBL] [Abstract][Full Text] [Related]
17. Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design.
Moehler M; Ryu MH; Dvorkin M; Lee KW; Coşkun HŞ; Wong R; Chung HC; Poltoratsky A; Tsuji A; Yen CJ; Muntean AS; Le Sourd S; Vaccaro GM; Overton L; Boku N; Wainberg ZA; Patel M; Sharma M; Xiong H; Conti I; Taieb J; Bang YJ
Future Oncol; 2019 Feb; 15(6):567-577. PubMed ID: 30379568
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.
Marabelle A; Le DT; Ascierto PA; Di Giacomo AM; De Jesus-Acosta A; Delord JP; Geva R; Gottfried M; Penel N; Hansen AR; Piha-Paul SA; Doi T; Gao B; Chung HC; Lopez-Martin J; Bang YJ; Frommer RS; Shah M; Ghori R; Joe AK; Pruitt SK; Diaz LA
J Clin Oncol; 2020 Jan; 38(1):1-10. PubMed ID: 31682550
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies.
Soyano AE; Dholaria B; Marin-Acevedo JA; Diehl N; Hodge D; Luo Y; Manochakian R; Chumsri S; Adjei A; Knutson KL; Lou Y
J Immunother Cancer; 2018 Nov; 6(1):129. PubMed ID: 30470260
[TBL] [Abstract][Full Text] [Related]
20. Acquired resistance to immunotherapy in MMR-D pancreatic cancer.
Hu ZI; Hellmann MD; Wolchok JD; Vyas M; Shia J; Stadler ZK; Diaz LA; O'Reilly EM
J Immunother Cancer; 2018 Nov; 6(1):127. PubMed ID: 30458888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
